On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
TuesdayNov 24, 2020 3:39 pm

NetworkNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Initiates Clinical Evaluation of CaniSun(TM)

Jupiter Wellness (NASDAQ: JUPW), a developer of cannabidiol (“CBD”) based therapeutics and wellness products, today announced initiation of a clinical study of its CaniSun(TM) sunscreen lotion for the treatment of actinic keratosis (“AK”), the most common precancer that forms on the skin as a result of exposure to ultraviolet (“UV”) rays. The clinical study’s primary objective is to evaluate Canisun as a treatment for AK by reviewing the efficacy in both treatment and prophylaxis of patients. The study, to be conducted by Applied Biology (Irvine, California), will recruit an estimated 116 adults diagnosed with AK. “I am excited to work…

Continue Reading

TuesdayNov 24, 2020 3:20 pm

NetworkNewsBreaks – ev Transportation Services Inc. (‘evTS’) Engages InvestorBrandNetwork for Corporate Communications Expertise

ev Transportation Services (“evTS”), a specialty vehicle OEM, today announced it has selected the corporate communications expertise of the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. Under the partnership, IBN will leverage its investor-based distribution network of 5,000+ key syndication outlets, various newsletters, social media channels, wire services via InvestorWire, blogs and other outreach tools to generate greater awareness for evTS. “The essential services vehicle fleet represents an annual domestic replacement market of approximately 100,000 vehicles. These vehicles roughly translate to a $2.5 billion market opportunity each year,” said Chris Johnson, director of…

Continue Reading

TuesdayNov 24, 2020 3:19 pm

NetworkNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) to Ring Nasdaq Opening Bell

180 Life Sciences (NASDAQ: ATNF, ATNFW), a clinical-stage biotechnology company with its lead indication in phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced that, in celebration of its recently completed initial public offering, it will ring the Nasdaq Stock Exchange opening bell on November 27, 2020. 180 Life Sciences CEO Dr. James Woody will be joined by members of the ATNF team for the virtual ceremony, which will begin at approximately 9:20 a.m. Eastern Time, and can be viewed live at  https://nnw.fm/faqOg, as well as on the…

Continue Reading

TuesdayNov 24, 2020 2:50 pm

NetworkNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Featured in Korea Biomedical Review Article

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, was featured in a recent article published in the Korea Biomedical Review. The piece, titled “Yuhan emerges as global new-drug developer with $3.6 billion tech export,” discusses Yuhan Corp.’s (OCT: YUHNF) move to enter technology transfer deals with global pharmaceutical companies, including Janssen Biotech, Gilead Sciences Inc. (NASDAQ: GILD), Boehringer Ingelheim and Processa. The article reads, “Yuhan also made a $410.5 million contract with the U.S. Processa Pharmaceuticals in 2020 for transferring the technology of…

Continue Reading

TuesdayNov 24, 2020 2:09 pm

NetworkNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Begins Strategic Greater Bay Area Expansion

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a leading producer, developer and operator of augmented reality ("AR") interactive entertainment games, toys and educational materials in China, today announced its entry into an agreement with three preschools (the First and Fourth Preschools and the Children's Center) of Guangzhou Development District Talent Work Group of Augmented Reality Immersive Classes (“ARIC”). According to the update, the move marks the beginning of Blue Hat's strategic expansion in the Guangdong -Hong Kong-Macao Greater Bay Area (the “Greater Bay Area”). “I am pleased with Blue Hat's cooperation with three preschools in Guangzhou. At present, we have…

Continue Reading

TuesdayNov 24, 2020 1:51 pm

NetworkNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Featured in Stock2Me Podcast

AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, was featured in InvestorBrandNetwork’s (“IBN”) latest episode of its Stock2Me Podcast. Stock2Me Podcasts feature a fascinating array of companies and individuals, many of whom are revolutionizing business practices within their respective markets. AZRX president and CEO James Sapirstein joins IBN’s Stuart Smith in the latest episode to discuss how AzurRx is working to redefine the standard of care for patients living with cystic fibrosis and chronic pancreatitis. “AzurRx Bio has been around for five years. … Our main product, MS1819, is being studied in…

Continue Reading

TuesdayNov 24, 2020 1:24 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Discusses Brain Cancer Drug During Syndicated Broadcast

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the central nervous system, is featured in a recent NetworkNewsAudio (“NNA”) broadcast. During the broadcast, CNS Pharmaceuticals CEO John Climaco explains that the company has recently submitted an investigational new drug (“IND) application to the U.S. Food & Drug Administration (“FDA”) for its brain cancer drug, Berubicin. Climaco also discusses CNSP’s intent to begin Phase 2 trials of the drug during Q1 2021. The Phase 2 trial is designed to analyze the efficacy of Berubicin in treating patients with Glioblastoma…

Continue Reading

TuesdayNov 24, 2020 1:04 pm

NetworkNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Present at Diamond Equity Research Emerging Growth Invitational

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that it will participate at the Diamond Equity Research Emerging Growth Invitational taking place virtually on Dec. 1, 2020. According to the update, Genprex’s executive vice president and COO, Michael Redman, will virtually deliver a company overview to investors followed by a guided question and answer session. Redman’s presentation is scheduled to begin at 11:30 a.m. ET on Dec. 1. Interested parties may visit https://www.nnw.fm/BjNia to register for the webinar. A live audio webcast and archive of the conference presentation…

Continue Reading

TuesdayNov 24, 2020 12:36 pm

NetworkNewsBreaks – Siyata Mobile Inc. (NASDAQ: SYTA) to Expand UV350 Offering to New Market Verticals in Europe

Siyata Mobile (NASDAQ: SYTA, SYTAW), a business-to-business (“B2B”) global vendor of next-generation cellular solutions, today announced its entry into a distribution agreement with pei tel Communications GmbH, a distributor based in Germany, for its Siyata UV350. According to the update, pei tel’s distribution countries include Germany, Austria, Switzerland, Belgium, Netherlands, and Luxembourg. “We are extremely excited to partner with pei tel to expand our Siyata UV350 offering to new market verticals in Europe,” said Marc Seelenfreund, CEO of Siyata Mobile. “This is a fantastic opportunity for Siyata to engage with new European clientele in an effort to become a leading…

Continue Reading

TuesdayNov 24, 2020 12:11 pm

NetworkNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) to Present at H.C. Wainwright Virtual Mining Conference

Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S.-based uranium mining company, today announced that its president and CEO, Mark S. Chalmers, will present at the H.C. Wainwright Mining Conference slated to be held on Nov. 30 and Dec. 1, 2020. Chalmers’ presentation is scheduled to begin at 3:00 p.m. ET on Monday, Nov. 30, where he will provide an update on the company, including progress on its uranium and rare earth element (“REE”) initiatives. Chalmers will also be available to participate in one-on-one meetings with investors registered to attend the conference via Zoom. Interested parties may visit https://www.nnw.fm/KyUwD…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217